Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00411905
Status:
UNKNOWN
Last Update Posted:
2007-03-12
First Post:
2006-12-14
Brief Title:
Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Groupe Francophone des Myelodysplasies
Organization Data
Organization:
Groupe Francophone des Myelodysplasies
Class:
OTHER
Study ID:
GFM BAR-C-2005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Groupe Francophone des Myelodysplasies
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None